Your browser doesn't support javascript.
loading
COVID-19 Vaccination Status and Hesitancy among Breast Cancer Patients after Two Years of Pandemic: A Cross-Sectional Survey.
Liu, Weijing; Wu, Yunhao; Yang, Ruoning; Chen, Ruixian; Huang, Ya; Zhao, Xin; Xie, Min; Li, Qintong; Wang, Qiang; Chen, Jie.
Afiliación
  • Liu W; Department of Breast Center, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Wu Y; Department of Breast Center, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Yang R; Department of Breast Center, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Chen R; Department of Breast Center, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Huang Y; Department of Breast Center, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Zhao X; Department of Breast Center, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Xie M; Mental Health Centre, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Li Q; Departments of Obstetrics & Gynecology and Pediatrics, West China Second University Hospital, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province, Sichuan Univ
  • Wang Q; Mental Health Centre, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Chen J; Department of Breast Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Vaccines (Basel) ; 10(9)2022 Sep 15.
Article en En | MEDLINE | ID: mdl-36146608
Background: Patients with cancer show greater susceptibility and vulnerability to severe acute respiratory syndrome coronavirus 2 infection. However, data on the vaccination status among patients with breast cancer and any structured analysis of the factors influencing patients' decisions regarding vaccines are lacking. Methods: This cross-sectional study on patients with breast cancer in China was conducted from 1 June 2022, to 17 June 2022. Every participant completed an online questionnaire about their vaccination status and any adverse reactions, and a scale based on the Health Belief Model (HBM) to assess the vaccination status of respondents and their willingness to receive following doses or boosters. Results: Among the 1132 participants, 55.2% had received a COVID-19 vaccine. The incidence of adverse events per dose was around 40%. Vaccine hesitancy of 61.9% was observed among patients who had not fully received three doses of vaccine or boosters. The only variable found to be associated with vaccine hesitancy was time since diagnosis (p < 0.05). In the HBM scale, vaccine hesitancy was closely related to a low level of perceived susceptibility, a low level of perceived benefit, a high level of perceived barriers and a low level of agreement with doctors' advice. Conclusions: For patients with breast cancer, perceived susceptibility, benefits and barriers should be prioritized, and the advice from authoritative doctors is a vital cue to action.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Vaccines (Basel) Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Vaccines (Basel) Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza